Primary Placental Dysfunction Development Features in Women at High Risk and the Prognostic Value of Biochemical Screening

Subject Areas : Journal of Chemical Health Risks

Iryna Marynchyna ¹ , Svitlana Pecheriaha ²

1 - Department of Obstetrics, Gynecology and Perynatology, Bukovinian State Medical University, Chernivtsi, Ukraine
2 - Department of Obstetrics, Gynecology and Perynatology, Bukovinian State Medical University, Chernivtsi, Ukraine

Received: 2021-07-30 Accepted : 2021-11-05 Published : 2021-10-01

Keywords:

References:

1. Zelinsky A.A., Karaush E.A., 2005. Perinatal Losses and Risk Factors of Obstetric and Gynecological Pathology, Kyiv: Intermed.


2. Milovanov A.P., 1999. Pathology of the Mother – Placenta – Foetus System, Moscow: Meditsina.


3. Sidelnikova V.M., 2011.Preparation and Management of Pregnancy in Women with Recurrent Miscarriage, Moscow: MEDpress-Inform.


4. Strizhakov A.N. Ignatko I.V., 2007. Loss of Pregnancy, Moscow: Medical Information Agency.


5. Azziz R., Nestler J.E., Dewailly D., 2006. Androgen Excess Disorders in Women: Polycystic Ovari Syndrome and Other Disorders, Totowa: Humana Press.


6. Beer A.E., Kwak J., 2000. Reproductive medicine program. Chicago Medical School. 11, 201-240.


7. Cuckle H.S., 2010. Monitoring quality control of nuchal translucency. Clinics in Laboratory Medicine. 30, 593-604.


8. Strukov A.I., Serov V.V., 2010. Pathological Anatomy, Moscow: Litterra.


9. Ailamazyan E.K. Obstetrics., 2005. Gynaecology, Moscow: SpetsLit.


10. Bodyazhina V.I., Zhmakin K.N., Kiryushchenkov A.P., 1986.Obstetrics, Moscow: Meditsina.


11. Mikhailenko E.T., 1982. Physiological Obstetrics, Kyiv: Vyshcha shkola.


12. Serov V.N., Strizhakov A.N., Markin S.A., 1989. Practical Obstetrics. A Guide for Doctors, Moscow: Meditsina.


13. Gavrilova L.V., 2000. On postcoital contraception. Family Planning Magazine. 1, 45-53.


14. Saidova R.A., 2000. Modern contraceptives. Family Planning Magazine. 2, 89-94.


15. Politaev G.F., 2000. Contraception: Options of choice. Family Doctor. 18, 111-117.


16. Savelyeva I.S., 1999. Influence hormonal contraceptives for the risk of developing breast cancer. Gynaecology. 1, 2-7.


17. Ketting E., Visser A.P., 1996. Contraception in the Netherlands: Low abortion rate. Family Planning Magazine. 4, 67-81.


18. Amin S.B., Sinkin R.A., Glantz J.C., 2007. Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes. American Journal of Obstetrics & Gynaecology. 197, 486.


19. Mittendorf R., Dambrosia J., Pryde P.G., 2002. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. American Journal of Obstetrics & Gynaecology. 186, 1111


20. Stika C.S., Gross G.A., Leguizamon G., 2002. A prospective randomised safety trial of celecoxib for treatment of preterm labour. American Journal of Obstetrics & Gynaecology. 187, article number 653.


21. Goldenberg R.L., 2002. The management of preterm labour. American Journal of Obstetrics & Gynaecology. 100, 1020.


22. Simhan H.N., Caritis S.N., 2007. Prevention of preterm delivery. The New England Journal of Medicine. 13, 75-81.